The global post-traumatic stress disorder treatment market size was US$ 16.0 billion in 2021. The global post-traumatic stress disorder treatment market size is estimated to reach US$ 24.6 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.9% during the forecast period from 2022 to 2030.
Post-traumatic stress disorder is a mental disease that one can get after exposure to traumatic circumstances, such as warfare, sexual assault, traffic collisions, child abuse, or other hazards to an individual's life. Symptoms of it can be rapid after experiencing a traumatic occurrence or they might not appear for years after the event including ignorance of something that triggers someone of the trauma, intrusive memories or reliving of the incident, and harmful changes in thinking or mood which interfere with everyday functioning, and disturbance in the individual's emotional reactions to daily events.
Factors Affecting Market Growth
An increase in the number of clinical practices on the treatment of post-traumatic stress disorder, as well as a growth in research and development activities for the growth of drugs and novel treatments, are the key factors that boost the global market.
Rising demand for antidepressant pills against post-traumatic stress disorder and growth in healthcare costs in developing countries are the key factors driving the global market.
The rising cost of the treatment and the side effects associated with the treatment of the disorder are the primary factors that hinder the global market.
The Rising demand for PTSD therapeutics across the world due to the rise in the spread of post-traumatic stress disorder and the growth in actions taken by governments for treating their war vets also driving the global market.
Impact Analysis of COVID-19
COVID-19 impact had a positive impact on the global market due to the rise in product sales for strengthening its conditions. According to a survey conducted by WHO, about 60% of the high-income countries supplied teletherapy consultation and telemedicine to patients with extreme signs of post-traumatic stress disorder. Pharmaceutical Companies in the pandemic concentrated on keeping a balance between demand and supply thus maintaining their drug sale undamaged. Also, due to COVID-19 enormous number of patients noticed a decline in psychotherapies which led to a growth in the adoption of medication and drugs intended for the treatment thus driving the global market.
North America dominated the global market share in 2020 and is expected to remain highest during the forecast period. Leading to the growth in research and development activities and the rising limitation of post-traumatic stress disorder as well as the existence of powerful and specified market performers in the region. Asia-Pacific is expected to notice lucrative expansion because of the drift in the aging population and the increase in the number of sexual and mental abuse among adults which drives the global market in the region.
The prominent players in the post-traumatic stress disorder market are:
Eily Lilly and Company
North Range Behavioral Health
Strategic Behavioral Health
Caretech Holdings PLC
Behavioral Health Network Inc
The global post-traumatic stress disorder market focuses on Treatment Type, Age Group, End-User, and Region
Segmentation on the basis of Treatment Type
Segmentation on the basis of Age Group
Segmentation on the basis of End-User
Mental Health Centres
Segmentation on the basis of Region
Rest of Western Europe
Rest of Eastern Europe
Australia & New Zealand
Rest of Asia Pacific
Middle East & Africa (MEA)
Rest of MEA
Rest of South America